89bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $151,204,000.

Profit Margin

89bio, Inc. (NASDAQ:ETNB): Profit margin
2018 0 -16.17M
2019 0 -57.42M
2020 0 -49.49M
2021 0 -90.12M
2022 0 -102.02M
2023 0 -142.18M

ETNB Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
000000
Cost of revenue
273K240K79K60K17K0
Gross profit
-273K-240K-79K-60K-17K0
Operating exp.
Research and development
122.23M80.79M70.33M36.19M21.34M13.68M
Selling and marketing
000000
Total operating expenses
151.20M102.24M89.74M49.35M26.64M15.16M
Operating income
-151.20M102.24M-89.74M-49.35M-26.64M-15.16M
Other income (expenses), net
12.88M-204.25M-526K-203K-30.56M-986K
Income before tax
-138.32M-102.00M-90.26M-49.55M-57.20M-16.14M
Income tax expense
3.86M19K-147K-59K218K28K
Net income
-142.18M-102.02M-90.12M-49.49M-57.42M-16.17M
Earnings per share
Basic EPS
-2-2.93-4.48-3.08-24.49-3.53
Diluted EPS
-2-2.93-4.48-3.08-24.49-3.53
Data sourceData sourceData sourceData sourceData source